Alternative strategies for Clostridium difficile infection

International Journal of Antimicrobial Agents

Volumn 33, Issue SUPPL. 1, 2009, Pages

  Bauer, Martijn P ^a   van Dissel, Jaap T ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Anti Clostridium difficile whey concentrate; Clostridium difficile; Faecotherapy; Immunotherapy; Polymers; Probiotics

Indexed keywords

BACITRACIN; COLESTIPOL; IMMUNOGLOBULIN; METRONIDAZOLE; PLACEBO; PROBIOTIC AGENT; TOLEVAMER; VANCOMYCIN;

ARTICLE; BACTERIAL COLONIZATION; CLINICAL TRIAL; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; COMORBIDITY; DRUG MEGADOSE; HUMAN; IMMUNOTHERAPY; INFECTION RISK; LACTOBACILLUS; LACTOBACILLUS PLANTARUM; LOW DRUG DOSE; PRIORITY JOURNAL; SACCHAROMYCES BOULARDII;

ANTIBIOSIS; CLOSTRIDIUM DIFFICILE; ENTEROCOLITIS, PSEUDOMEMBRANOUS; HUMANS; IMMUNOTHERAPY; PROBIOTICS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 62249160649     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(09)70018-4     Document Type: Article

References (33)

1. Gerding D.N., Muto C.A., and Owens R.C. Measures to control and prevent Clostridium difficile infection. Clin Infect Dis 46 (2008) S43-S49
2. Kuijper E.J., van Dissel J.T., and Wilcox M.H. Clostridium difficile: changing epidemiology and new treatment options. Curr Opin Infect Dis 20 (2007) 376-383
3. Gerding D.N., Muto C.A., and Owens R.C. Treatment of Clostridium difficile infection. Clin Infect Dis 46 (2008) S32-S42
4. McFarland L.V. Alternative treatments for Clostridium difficile disease: what really works?. J Med Microbiol 54 (2005) 101-111
5. Wilcox M.H., and Spencer R.C. Clostridium difficile infection: responses, relapses and re-infections. J Hosp Infect 22 (1992) 85-92
6. McFarland L.V., Surawicz C.M., Greenberg R.N., Fekety R., Elmer G.W., Moyer K.A., et al. A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. J Am Med Assoc 271 (1994) 1913-1918
7. Louie T.J., Peppe J., Watt C.K., Johnson D., Mohammed R., Dow G., et al. Tolevamer, a novel nonantibiotic polymer, compared with vancomycin in the treatment of mild to moderately severe Clostridium difficile-associated diarrhea. Clin Infect Dis 43 (2006) 411-420
8. Louie TJ, Gerson M, Grimard D, Johnson S, Poirier A, Weiss K, et al. Results of a phase III trial comparing tolevamer, vancomycin and metronidazole in patients with Clostridium difficile-associated diarrhea (CDAD). In: Program and abstracts of the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy, 17 20 September 2007, Chicago, USA. Abstract K-425a.
9. Bouza E, Dryden M, Mohammed R, Peppe J, Chasan-Taber S, Donovan J, et al. Results of a phase III trial comparing tolevamer, vancomycin and metronidazole in patients with Clostridium difficile-associated diarrhoea. In: Program and abstracts of the 18th European Congress of Clinical Microbiology and Infectious Diseases, 19 22 April 2008, Barcelona, Spain. Abstract O464.
10. Mogg G.A., George R.H., Youngs D., Johnson M., Thompson H., Burdon D.W., et al. Randomised controlled trial of colestipol in antibiotic-associated colitis. Br J Surg 69 (1982) 137-139
11. Van Dissel J.T., de Groot N., Hensgens C.M.H., Numan S., Kuijper E.J., Veldkamp P., et al. Bovine antibody-enriched whey to aid in the prevention of a relapse of Clostridium difficile associated diarrhoea: preclinical and preliminary clinical data. J Med Microbiol 54 (2005) 197-205
12. Numan S., Veldkamp P., Kuijper E.J., van den Berg R.J., and van Dissel J.T. Clostridium difficile-associated diarrhea: bovine anti-Clostridium difficile whey protein to help aid the prevention of relapses. Gut 56 (2007) 888-889
13. Surawicz C.M., McFarland L.V., Greenberg R.N., Rubin M., Fekety R., Mulligan M.E., et al. The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii. Clin Infect Dis 31 (2000) 1012-1017
14. Wullt M., Hagslätt M.L., and Odenholt I. Lactobacillus plantarum 299v for the treatment of recurrent Clostridium difficile-associated diarrhoea: a doubleblind, placebo-controlled trial. Scand J Infect Dis 35 (2003) 365-367
15. Lawrence S.J., Korzenik J.R., and Mundy L.M. Probiotics for recurrent Clostridium difficile disease. J Med Microbiol 54 (2005) 905-906
16. Mattila E., Anttila V.J., Broas M., Marttila H., Poukka P., Kuusisto K., et al. A randomized, double-blind study comparing Clostridium difficile immune whey and metronidazole for recurrent Clostridium difficile-associated diarrhoea: Efficacy and safety data of a prematurely interrupted trial. Scand J Infect Dis 40 (2008) 702-708
17. Gorbach S.L., Chang T.W., and Goldin B. Successful treatment of relapsing Clostridium difficile colitis with Lactobacillus GG. Lancet 2 (1987) 1519
18. Biller J.A., Katz A.J., Flores A.F., Buie T.M., and Gorbach S.L. Treatment of recurrent Clostridium difficile colitis with Lactobacillus GG. J Pediatr Gastroenterol Nutr 21 (1995) 224-226
19. Bowden Jr. T.A., Mansberger Jr. A.R., and Lykins L.E. Pseudomembraneous enterocolitis: mechanism for restoring floral homeostasis. Am Surg 47 (1981) 178-183
20. Tvede M., and Rask-Madsen J. Bacteriotherapy for chronic relapsing Clostridium difficile diarrhoea in six patients. Lancet 1 (1989) 1156-1160
21. Lund-Tønnesen S., Berstad A., Schreiner A., and Midtvedt T. Clostridium difficile-associated diarrhea treated with homologous feces. Tidsskr Nor Laegeforen 118 (1998) 1027-1030
22. Aas J., Gessert C.E., and Bakken J.S. Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube. Clin Infect Dis 36 (2003) 580-585
23. Jorup-Rönström C., Håkanson A., Persson A.K., Midtvedt T., and Norin E. Feces culture successful therapy in Clostridium difficile diarrhea. Lakartidningen 103 (2006) 3603-3605
24. Nieuwdorp M., van Nood E., Speelman P., van Heukelem H.A., Jansen J.M., Visser C.E., et al. Behandeling van recidiverende Clostridium difficile-geassocieerde diarree met een suspensie van donorfeces. Ned Tijdschr Geneesk 35 (2008) 1927-1933
25. Leung D.Y., Kelly C.P., Boguniewicz M., Pothoulakis C., LaMont J.T., and Flors A. Treatment with intravenously administered gamma globulin of chronic relapsing colitis induced by Clostridium difficile toxin. J Pediatr 118 (1991) 633-637
26. Beales I.L. Intravenous immunoglobulin for recurrent Clostridium difficile diarrhoea. Gut 51 (2002) 456
27. Bakken S. Novel therapies for Clostridium difficile disease. In: Program and abstracts of the 45th Annual Meeting of the Infectious Disease Society of America, 4 7 October 2007, San Diego, USA. Oral session 611.
28. Sambol S.P., Merrigan M.M., Tang J.K., Johnson S., and Gerding D.N. Colonization for the prevention of Clostridium difficile disease in hamsters. J Infect Dis 186 (2002) 1781-1789
29. Pillai A., and Nelson R. Probiotics for treatment of Clostridium difficile-associated colitis in adults. Cochrane Database Syst Rev 1 (2008) CD004611.
30. Besselink M.G., van Santvoort H.C., Buskens E., Boermeester M.A., van Goor H., Timmerman H.M., et al. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet 371 (2008) 651-659
31. Wilcox M.H. Descriptive study of intravenous immunoglobulin for the treatment of recurrent Clostridium difficile diarrhoea. J Antimicrob Chemother 53 (2004) 882-884
32. Young K.W.H., Munro K.C., Taylor S.L., Veldkamp P.J., and Van Dissel J.T. The safety of whey protein concentrate derived from the milk of cows immunized against Clostridium difficile. Regul Toxicol Pharmacol 47 (2007) 317-326
33. Bauer M.P., Numan-Ruberg S.C., Bredewold O.W., Kuijper E.J., Mooi-Kokenberg E.A., DeBast S.B., et al. Recidieven van Clostridium difficile-geassocieerde diarree voorkomen door toediening van een weiconcentraat van specifiek geimmuniseerde koeien; prospectief onderzoek. Ned Tijdschr Geneesk 35 (2008) 1919-1927